Nurulamin M Noor1, Paul J R Banim, Robert N Luben, Kay-Tee Khaw, Andrew R Hart. 1. From the *Department of Medicine, University of Cambridge, Cambridge, United Kingdom; †Department of Gastroenterology, James Paget University Hospital, Great Yarmouth, United Kingdom; ‡Institute of Public Health, University of Cambridge, Cambridge, United Kingdom; and §Department of Medicine, Norwich Medical School, University of East Anglia, Norwich, United Kingdom.
Abstract
OBJECTIVES: There are plausible biological mechanisms for how increased physical activity (PA) may prevent pancreatic cancer, although findings from epidemiological studies are inconsistent. We investigated whether the risk is dependent on the age at which PA is measured and if independent of body mass index (BMI). METHODS: A total of 23,639 participants, aged 40 to 74 years, were recruited into the EPIC-Norfolk (European Prospective Investigation of Cancer) cohort study between 1993 and 1997 and completed validated questionnaires on PA. The cohort was monitored for pancreatic cancer development, and hazard ratios (HRs) were estimated and adjusted for covariates. RESULTS: Within 17 years, 88 participants developed pancreatic cancer (55% female). There was no association between PA and risk in the cohort (HR trend, 1.06; 95% confidence interval [CI], 0.86-1.29). However, in participants younger than 60 years, higher PA was associated with decreased risk (highest vs lowest category HR, 0.27; 95% CI, 0.07-0.99). Higher PA was not inversely associated when older than 60 years (HR trend, 1.23; 95% CI, 0.96-1.57). Including BMI in all models produced similar estimates. CONCLUSIONS: The reasons why PA in younger, but not older, people may prevent pancreatic cancer need to be investigated. Physical activity may operate through mechanisms independent of BMI. If this association is causal, 1 in 6 cases might be prevented by encouraging more PA.
OBJECTIVES: There are plausible biological mechanisms for how increased physical activity (PA) may prevent pancreatic cancer, although findings from epidemiological studies are inconsistent. We investigated whether the risk is dependent on the age at which PA is measured and if independent of body mass index (BMI). METHODS: A total of 23,639 participants, aged 40 to 74 years, were recruited into the EPIC-Norfolk (European Prospective Investigation of Cancer) cohort study between 1993 and 1997 and completed validated questionnaires on PA. The cohort was monitored for pancreatic cancer development, and hazard ratios (HRs) were estimated and adjusted for covariates. RESULTS: Within 17 years, 88 participants developed pancreatic cancer (55% female). There was no association between PA and risk in the cohort (HR trend, 1.06; 95% confidence interval [CI], 0.86-1.29). However, in participants younger than 60 years, higher PA was associated with decreased risk (highest vs lowest category HR, 0.27; 95% CI, 0.07-0.99). Higher PA was not inversely associated when older than 60 years (HR trend, 1.23; 95% CI, 0.96-1.57). Including BMI in all models produced similar estimates. CONCLUSIONS: The reasons why PA in younger, but not older, people may prevent pancreatic cancer need to be investigated. Physical activity may operate through mechanisms independent of BMI. If this association is causal, 1 in 6 cases might be prevented by encouraging more PA.
Authors: Ute Nöthlings; Lynne R Wilkens; Suzanne P Murphy; Jean H Hankin; Brian E Henderson; Laurence N Kolonel Journal: Cancer Causes Control Date: 2007-01-11 Impact factor: 2.506
Authors: Nicholas J Wareham; Rupert W Jakes; Kirsten L Rennie; Jantine Schuit; Jo Mitchell; Susie Hennings; Nicholas E Day Journal: Public Health Nutr Date: 2003-06 Impact factor: 4.022
Authors: Rachael Z Stolzenberg-Solomon; Pirjo Pietinen; Philip R Taylor; Jarmo Virtamo; Demetrius Albanes Journal: Cancer Causes Control Date: 2002-06 Impact factor: 2.506
Authors: Amy Berrington de González; Elizabeth A Spencer; H Bas Bueno-de-Mesquita; Andrew Roddam; Rachel Stolzenberg-Solomon; Jytte Halkjaer; Anne Tjønneland; Kim Overvad; Francoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Heiner Boeing; Tobias Pischon; Jakob Linseisen; Sabine Rohrmann; Antonia Trichopoulou; Vassiliki Benetou; Aristoteles Papadimitriou; Valeria Pala; Domenico Palli; Salvatore Panico; Rosario Tumino; Paolo Vineis; Hendriek C Boshuizen; Marga C Ocke; Petra H Peeters; Eiliv Lund; Carlos A Gonzalez; Nerea Larrañaga; Carmen Martinez-Garcia; Michelle Mendez; Carmen Navarro; J Ramón Quirós; María-José Tormo; Göran Hallmans; Weimin Ye; Sheila A Bingham; Kay-Tee Khaw; Naomi Allen; Tim J Key; Mazda Jenab; Teresa Norat; Pietro Ferrari; Elio Riboli Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-05 Impact factor: 4.254
Authors: Alec J Beaney; Paul J R Banim; Robert Luben; Marleen A H Lentjes; Kay-Tee Khaw; Andrew R Hart Journal: Pancreas Date: 2017 May/Jun Impact factor: 3.327
Authors: Anne McTiernan; Christine M Friedenreich; Peter T Katzmarzyk; Kenneth E Powell; Richard Macko; David Buchner; Linda S Pescatello; Bonny Bloodgood; Bethany Tennant; Alison Vaux-Bjerke; Stephanie M George; Richard P Troiano; Katrina L Piercy Journal: Med Sci Sports Exerc Date: 2019-06 Impact factor: 5.411
Authors: M Pollán; S Casla-Barrio; J Alfaro; C Esteban; M A Segui-Palmer; A Lucia; M Martín Journal: Clin Transl Oncol Date: 2020-02-13 Impact factor: 3.405
Authors: Gali Cohen; David M Steinberg; Lital Keinan-Boker; Or Shaked; Abigail Goshen; Tal Shimony; Tamar Shohat; Yariv Gerber Journal: Mayo Clin Proc Innov Qual Outcomes Date: 2020-04-06